Treatment

There is currently no cure for Alzheimer’s disease. However, research into treatments that may slow the progression of the disease is ongoing and offers hope for the future.

Several medicines are available to help manage symptoms. These are known as symptomatic treatments because they may improve or temporarily stabilise certain cognitive symptoms, but they do not cure the disease or stop the underlying disease process.

Four medicines are commonly used to treat symptoms of Alzheimer’s disease: donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa). The choice of treatment depends on the stage of the disease, the person’s symptoms and their individual circumstances. These medicines may help some people maintain their cognitive abilities and everyday functioning for a time.

Depending on the person’s symptoms, a doctor may also prescribe other medicines, such as antidepressants to treat depression or, in specific circumstances, antipsychotics to manage severe behavioural symptoms. Any such treatment should be carefully assessed and monitored by a healthcare professional.

Non-Drug Therapies

Non-drug therapies also play an important role in the care of people living with Alzheimer’s disease. Their aim is to help people maintain their abilities, independence and quality of life for as long as possible.

Depending on individual needs, these interventions may include speech and language therapy, psychological support, neuropsychological rehabilitation and occupational therapy.

Workshops and activities focusing on cognitive stimulation, emotional wellbeing, artistic expression and physical activity may also be offered.

Depending on the person’s needs and the stage of the disease, day-care services may provide additional support, structured activities and opportunities for social interaction.

A Comprehensive Approach to Care

At every stage of Alzheimer’s disease, preserving the person’s independence and quality of life, while supporting their family and carers, remains a central priority.

Care should take a comprehensive, personalised approach that addresses the neurological, psychological, behavioural and social aspects of the disease.